Adenosine technetium-99m sestamibi myocardial perfusion SPECT in women: diagnostic efficacy in detection of coronary artery disease
AM Amanullah,
H Kiat,
JD Friedman,
and
DS Berman
Department of Medicine, Nuclear Cardiology, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.
OBJECTIVES. This study sought to assess the diagnostic efficacy of adenosine technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography (SPECT) in a consecutive series of female patients. BACKGROUND. The utility of adenosine myocardial perfusion SPECT for the detection of coronary artery disease is not well defined in women because most studies have described a predominantly male population with a high prevalence of coronary artery disease. METHODS. Of the 201 consecutive female patients in the study group who had undergone adenosine Tc-99m sestamibi myocardial perfusion SPECT, 130 had coronary angiography within 2 months of the nuclear test, and the other 71 had a low likelihood (<10%, mean [+/-SD] 5 +/- 3%) of coronary artery disease. The SPECT protocol used separate acquisition of rest thallium-201 and adenosine Tc-99m sestamibi and was visually analyzed in 20 segments with a semiquantitative five-point scoring system (0=normal; 4=absent uptake). RESULTS. The normalcy rate in patients with a low likelihood of coronary artery disease was 93% (66 of 71). Among the catheterized group, the overall sensitivity, specificity and predictive accuracy of adenosine sestamibi SPECT for detecting coronary artery disease (> or = to 50% diameter stenosis) were 93% (87 of 94), 78% (28 of 36) and 88% (115 of 130), respectively. In the 103 patients without a prior myocardial infarction, the sensitivity, specificity and predictive accuracy were 91% (61 of 67), 78% (28 of 36) and 86% (89 of 103), respectively, for detecting > or = to 50% diameter stenosis. Of particular interest, the sensitivity and specificity were as high in patients with nonanginal symptoms (93% and 69%, respectively) as in patients with angina (92% and 83%, respectively, p=NS). The sensitivity and specificity among patients with a relatively low (<25%), intermediate (between 25% and 75%) or high prescan likelihood of coronary artery disease (>75%) were similar: 82% and 82%, 93% and 73%, and 95% and 100%, respectively. The sensitivity and specificity for detecting individual diseased vessels (> or = to 50% diameter stenosis) were, respectively, 76% and 81% for the left anterior descending coronary artery, 44% and 90% for the left circumflex coronary artery and 75% and 77% for the right coronary artery. CONCLUSIONS. Adenosine Tc-99m sestamibi SPECT is an efficient protocol with high sensitivity and specificity for the detection of coronary artery disease in women irrespective of presenting symptoms or pretest likelihood of coronary artery disease and a high normalcy rate. These findings are of particular clinical relevance because chest pain, anginal or otherwise, has been shown to be a frequent but a less specific marker for coronary artery disease among female patients.
This article has been cited by other articles:

|
 |

|
 |
 
R. C. Cury, T. Techasith, G. Feuchtner, and G. Dabus
Cardiovascular Disease and Stroke in Women: Role of Radiology
Am. J. Roentgenol.,
February 1, 2011;
196(2):
265 - 273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J.W. Chow, A. Abraham, G. A. Wells, L. Chen, T. D. Ruddy, Y. Yam, N. Govas, P. D. Galbraith, C. Dennie, and R. S. Beanlands
Diagnostic Accuracy and Impact of Computed Tomographic Coronary Angiography on Utilization of Invasive Coronary Angiography
Circ Cardiovasc Imaging,
January 1, 2009;
2(1):
16 - 23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Stangl, V. Witzel, G. Baumann, and K. Stangl
Current diagnostic concepts to detect coronary artery disease in women
Eur. Heart J.,
March 2, 2008;
29(6):
707 - 717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Scognamiglio, C. Negut, A. Ramondo, A. Tiengo, and A. Avogaro
Detection of Coronary Artery Disease in Asymptomatic Patients With Type 2 Diabetes Mellitus
J. Am. Coll. Cardiol.,
January 3, 2006;
47(1):
65 - 71.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Nishina, P. J. Slomka, A. Abidov, S. Yoda, C. Akincioglu, X. Kang, I. Cohen, S. W. Hayes, J. D. Friedman, G. Germano, et al.
Combined Supine and Prone Quantitative Myocardial Perfusion SPECT: Method Development and Clinical Validation in Patients with No Known Coronary Artery Disease
J. Nucl. Med.,
January 1, 2006;
47(1):
51 - 58.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Scognamiglio, C. Negut, A. Ramondo, A. Tiengo, and A. Avogaro
Detection of Coronary Artery Disease in Asymptomatic Patients With Type 2 Diabetes Mellitus
J. Am. Coll. Cardiol.,
December 13, 2005;
(2005)
j.jacc.2005.10.008v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. D. Wong, A. Rozanski, H. Gransar, R. Miranda-Peats, X. Kang, S. Hayes, L. Shaw, J. Friedman, D. Polk, and D. S. Berman
Metabolic Syndrome and Diabetes Are Associated With an Increased Likelihood of Inducible Myocardial Ischemia Among Patients With Subclinical Atherosclerosis
Diabetes Care,
June 1, 2005;
28(6):
1445 - 1450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Y Loong and C Anagnostopoulos
Diagnosis of coronary artery disease by radionuclide myocardial perfusion imaging
Heart,
August 1, 2004;
90(suppl_5):
v2 - v9.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Slomka, H. Nishina, D. S. Berman, X. Kang, J. D. Friedman, S. W. Hayes, U. E. Aladl, and G. Germano
Automatic Quantification of Myocardial Perfusion Stress-Rest Change: A New Measure of Ischemia
J. Nucl. Med.,
February 1, 2004;
45(2):
183 - 191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Committee Members, F. J. Klocke, M. G. Baird, B. H. Lorell, T. M. Bateman, J. V. Messer, D. S. Berman, P. T. O'Gara, B. A. Carabello, R. O. Russell Jr, et al.
ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging)
J. Am. Coll. Cardiol.,
October 1, 2003;
42(7):
1318 - 1333.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Klocke, M. G. Baird, B. H. Lorell, T. M. Bateman, J. V. Messer, D. S. Berman, P. T. O'Gara, B. A. Carabello, R. O. Russell Jr, M. D. Cerqueira, et al.
ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging)
Circulation,
September 16, 2003;
108(11):
1404 - 1418.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Berman, X. Kang, S. W. Hayes, J. D. Friedman, I. Cohen, A. Abidov, L. J. Shaw, A. M. Amanullah, G. Germano, and R. Hachamovitch
Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men: Impact of diabetes mellitus on incremental prognostic value and effect on patient management
J. Am. Coll. Cardiol.,
April 2, 2003;
41(7):
1125 - 1133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-S. Jeon, S. Atar, A. V. Brasch, H. Luo, J. Mirocha, T. Z. Naqvi, R. Kraus, D. S. Berman, and R. J. Siegel
Association of mitral annulus calcification, aortic valve sclerosis and aortic root calcification with abnormal myocardial perfusion single photon emission tomography in subjects age <=65 years old
J. Am. Coll. Cardiol.,
December 1, 2001;
38(7):
1988 - 1993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Taki, S. Fujino, K. Nakajima, I. Matsunari, H. Okazaki, T. Saga, H. Bunko, and N. Tonami
99mTc-Sestamibi Retention Characteristics During Pharmacologic Hyperemia in Human Myocardium: Comparison with Coronary Flow Reserve Measured by Doppler Flowire
J. Nucl. Med.,
October 1, 2001;
42(10):
1457 - 1463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Wallis
Use of Artificial Intelligence in Cardiac Imaging
J. Nucl. Med.,
August 1, 2001;
42(8):
1192 - 1194.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-X. He, E. Cwajg, W. Hwang, C. J. Hartley, E. Funk, L. H. Michael, and M. S. Verani
Myocardial Blood Flow and Myocardial Uptake of 201Tl and 99mTc-Sestamibi During Coronary Vasodilation Induced by CGS-21680, a Selective Adenosine A2A Receptor Agonist
Circulation,
July 25, 2000;
102(4):
438 - 444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nishioka, A. M. Amanullah, H. Luo, H. Berglund, C.-J. Kim, T. Nagai, N. Hakamata, S. Katsushika, A. Uehata, B. Takase, et al.
Clinical validation of intravascular ultrasound imaging for assessment of coronary stenosis severity: Comparison with stress myocardial perfusion imaging
J. Am. Coll. Cardiol.,
June 1, 1999;
33(7):
1870 - 1878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
ADENOSINE SESTAMIBI SPECT IMAGING AS A TEST FOR CAD IN WOMEN
Journal Watch (General),
April 9, 1996;
1996(409):
6 - 6.
[Full Text]
|
 |
|
|